Conference Coverage ENDEAR Study Demonstrates Efficacy of Nusinersen in Infants With Spinal Muscular Atrophy BOSTON—Infants with spinal muscular atrophy (SMA) type 1 who were treated with nusinersen demonstrated clinically and... Read More